US 12318487
Solid tablet dosage form of ridinilazole
granted A61KA61K31/4439A61K31/444
Quick answer
US patent 12318487 (Solid tablet dosage form of ridinilazole) held by SUMMIT (OXFORD) LIMITED expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUMMIT (OXFORD) LIMITED
- Grant date
- Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K31/4439, A61K31/444, A61K47/26, A61K9/2018